BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yang XQ, Ye J, Li X, Li Q, Song YH. Pyrrolizidine alkaloids-induced hepatic sinusoidal obstruction syndrome: Pathogenesis, clinical manifestations, diagnosis, treatment, and outcomes. World J Gastroenterol 2019; 25(28): 3753-3763 [PMID: 31391770 DOI: 10.3748/wjg.v25.i28.3753] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 11] [Article Influence: 4.7] [Reference Citation Analysis]
Number Citing Articles
1 Wu F, Yu J, Gan H, Zhang H, Tian D, Zheng D. Timing and efficacy of transjugular intrahepatic portosystemic shunt in patients with pyrrolizidine alkaloid-induced hepatic sinusoidal obstruction syndrome. Sci Rep 2021;11:21743. [PMID: 34741082 DOI: 10.1038/s41598-021-01201-w] [Reference Citation Analysis]
2 Liu F, Rong X, Guo H, Xu D, Liu C, Meng L, Yang X, Guo T, Kan X, Song Y. Clinical characteristics, CT signs, and pathological findings of Pyrrolizidine alkaloids-induced sinusoidal obstructive syndrome: a retrospective study. BMC Gastroenterol 2020;20:30. [PMID: 32019495 DOI: 10.1186/s12876-020-1180-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
3 Yang X, Lei P, Song Y, Fei Z, Ai Y, Shang H, Bai T, Ye J, Li X. Quantitative CT assessment by histogram and volume ratio in pyrrolizidines alkaloids-induced hepatic sinusoidal obstruction syndrome. Eur J Radiol 2021;138:109632. [PMID: 33711570 DOI: 10.1016/j.ejrad.2021.109632] [Reference Citation Analysis]
4 Cen P, Ding J, Jin J. Hepatic sinusoidal obstruction syndrome caused by the ingestion of Gynura segetum in a patient with alcoholic cirrhosis: a case report. J Int Med Res 2021;49:300060520980649. [PMID: 33845617 DOI: 10.1177/0300060520980649] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Shang H, Bai T, Zhu S, Yang X, Liu C, Xu D, Zhuge Y, Song Y, Hou X. Prognostic factors for pyrrolizidine alkaloid-induced hepatic sinusoidal obstruction syndrome: a multicenter study in China. Ann Transl Med 2021;9:11. [PMID: 33553304 DOI: 10.21037/atm-20-731] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Wang X, Zhang W, Yang Y, Chen Y, Zhuge Y, Xiong A, Yang L, Wang Z. Blood microRNA Signatures Serve as Potential Diagnostic Biomarkers for Hepatic Sinusoidal Obstruction Syndrome Caused by Gynura japonica Containing Pyrrolizidine Alkaloids. Front Pharmacol 2021;12:627126. [PMID: 33679405 DOI: 10.3389/fphar.2021.627126] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Glück J, Henricsson M, Braeuning A, Hessel-Pras S. The Food Contaminants Pyrrolizidine Alkaloids Disturb Bile Acid Homeostasis Structure-Dependently in the Human Hepatoma Cell Line HepaRG. Foods 2021;10:1114. [PMID: 34069968 DOI: 10.3390/foods10051114] [Reference Citation Analysis]
8 Zhang C, Wu Z, Wang F, Shi L. Hepatic sinusoidal obstruction syndrome after oral intake of Gynura segetum. Asian J Surg 2021;44:991-3. [PMID: 33926799 DOI: 10.1016/j.asjsur.2021.04.015] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Liu JH, Yang H, Zhang L, Peng XR, Li ZJ, He MY, Wan LS, Li ZR, Zhou L, Liu ZH, Qiu MH. Pyrrolizidine alkaloids from the seeds of Scleropyrum wallichianum. J Asian Nat Prod Res 2021;23:407-13. [PMID: 32228193 DOI: 10.1080/10286020.2020.1740919] [Reference Citation Analysis]
10 Ma J, Li M, Li N, Chan WY, Lin G. Pyrrolizidine Alkaloid-Induced Hepatotoxicity Associated with the Formation of Reactive Metabolite-Derived Pyrrole-Protein Adducts. Toxins (Basel) 2021;13:723. [PMID: 34679016 DOI: 10.3390/toxins13100723] [Reference Citation Analysis]
11 Naito Y, Yoshinouchi Y, Sorayama Y, Kohara H, Kitano S, Irie S, Matsusaki M. Constructing vascularized hepatic tissue by cell-assembled viscous tissue sedimentation method and its application for vascular toxicity assessment. Acta Biomater 2022;140:275-88. [PMID: 34826641 DOI: 10.1016/j.actbio.2021.11.027] [Reference Citation Analysis]
12 Teschke R, Vongdala N, Quan NV, Quy TN, Xuan TD. Metabolic Toxification of 1,2-Unsaturated Pyrrolizidine Alkaloids Causes Human Hepatic Sinusoidal Obstruction Syndrome: The Update. Int J Mol Sci 2021;22:10419. [PMID: 34638760 DOI: 10.3390/ijms221910419] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Wang Z, Han H, Wang C, Zheng Q, Chen H, Zhang X, Hou R. Hepatotoxicity of Pyrrolizidine Alkaloid Compound Intermedine: Comparison with Other Pyrrolizidine Alkaloids and Its Toxicological Mechanism. Toxins (Basel) 2021;13:849. [PMID: 34941687 DOI: 10.3390/toxins13120849] [Reference Citation Analysis]
14 Dai F, Qiao W, Kang Z, Chen Y, Li K, Shen W, Zhang X. Clinical Features and CT Imaging Analysis of Hepatic Sinuscase-Syndrome and Budd–Chiari Syndrome. IJGM 2022;Volume 15:2389-96. [DOI: 10.2147/ijgm.s348176] [Reference Citation Analysis]
15 Xiao J, Tu J, Zhang H, Zhang F, Zhang W, Xu H, Yin Q, Yang J, Han H, Wang Y, Zhang B, Peng C, Zou X, Zhang M, Zhuge Y. Risk factors of poor prognosis in patients with pyrrolidine alkaloid-induced hepatic sinusoidal obstruction syndrome after transjugular intrahepatic portosystemic shunt. Hepatol Int 2021;15:720-9. [PMID: 33507485 DOI: 10.1007/s12072-020-10126-x] [Reference Citation Analysis]
16 Wang X, Zhang W, Zhang M, Zhang F, Xiao J, Yin Q, Han H, Li T, Lin G, Zhuge Y. Development of a Drum Tower Severity Scoring (DTSS) system for pyrrolizidine alkaloid-induced hepatic sinusoidal obstruction syndrome. Hepatol Int 2022. [PMID: 35023026 DOI: 10.1007/s12072-021-10293-5] [Reference Citation Analysis]
17 Zhang H, Jia S, Jin L, Mb JY, Shen Z, Wu J, Yao X, Chen D, Zhang C, Yu S, Zhu N, Jin L, Yao X. Gynura segetum induces hepatic sinusoidal obstruction syndrome in mice by impairing autophagy. Acta Cir Bras 2022;36:e361104. [PMID: 35195181 DOI: 10.1590/ACB361104] [Reference Citation Analysis]
18 Song YH, Xiang HY, Si KK, Wang ZH, Zhang Y, Liu C, Xu KS, Li X. Difference between type 2 gastroesophageal varices and isolated fundic varices in clinical profiles and portosystemic collaterals. World J Clin Cases 2022; 10(17): 5620-5633 [DOI: 10.12998/wjcc.v10.i17.5620] [Reference Citation Analysis]
19 Nunes DRDCMA, Monteiro CSDJ, dos Santos JL. Herb-Induced Liver Injury—A Challenging Diagnosis. Healthcare 2022;10:278. [DOI: 10.3390/healthcare10020278] [Reference Citation Analysis]
20 Jiang M, Wang L, Du X, Hao M, Gao P. Low molecular weight heparin in the treatment of pyrrolizidine alkaloid-induced hepatic sinusoidal obstruction syndrome: five case reports. J Int Med Res 2020;48:300060520961916. [PMID: 32993424 DOI: 10.1177/0300060520961916] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
21 Edgar JA, Molyneux RJ, Colegate SM. 1,2-Dehydropyrrolizidine Alkaloids: Their Potential as a Dietary Cause of Sporadic Motor Neuron Diseases. Chem Res Toxicol 2022. [PMID: 35238548 DOI: 10.1021/acs.chemrestox.1c00384] [Reference Citation Analysis]
22 Liu Y, Sun LY, Zhu ZJ, Wei L, Qu W, Zeng ZG. Is sinusoidal obstructive syndrome a recurrent disease after liver transplantation? A case report . World J Clin Cases 2021; 9(2): 489-495 [PMID: 33521120 DOI: 10.12998/wjcc.v9.i2.489] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]